Sudden Death and Left Ventricular Involvement in Arrhythmogenic Cardiomyopathy
暂无分享,去创建一个
E. Behr | M. Sheppard | S. Cook | A. Witney | J. Ware | J. Basu | J. Robertus | M. Papadakis | G. Finocchiaro | A. Malhotra | Sanjay Sharma | I. Ster | A. Asimaki | B. Gray | G. Parry-Williams | B. Ensam | C. Miles | M. Tome | J. Westaby | E. Papatheodorou | C. Paterson | M. Tomé
[1] Johan Duflou,et al. Concealed Arrhythmogenic Right Ventricular Cardiomyopathy in Sudden Unexplained Cardiac Death Events. , 2018, Circulation. Genomic and precision medicine.
[2] P. Schwartz,et al. Desmoplakin missense and non-missense mutations in arrhythmogenic right ventricular cardiomyopathy: Genotype-phenotype correlation. , 2017, International journal of cardiology.
[3] H. Calkins,et al. Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy , 2017, Circulation.
[4] B. Maron,et al. Classification, Epidemiology, and Global Burden of Cardiomyopathies. , 2017, Circulation research.
[5] J. Skinner,et al. Utility of Post-Mortem Genetic Testing in Cases of Sudden Arrhythmic Death Syndrome , 2017, Journal of the American College of Cardiology.
[6] Xiaoshu Cheng,et al. Genotype-phenotype relationship in patients with arrhythmogenic right ventricular cardiomyopathy caused by desmosomal gene mutations: A systematic review and meta-analysis , 2017, Scientific Reports.
[7] T. Chao,et al. Gender differences in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: Clinical manifestations, electrophysiological properties, substrate characteristics, and prognosis of radiofrequency catheter ablation. , 2017, International journal of cardiology.
[8] M. Link,et al. Arrhythmogenic Right Ventricular Cardiomyopathy. , 2017, The New England journal of medicine.
[9] M. Link,et al. Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators: Long-Term Results of a Prospective Multinational Registry. , 2013, Circulation.
[10] R. Bellazzi,et al. Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk. , 2016, Journal of the American College of Cardiology.
[11] E. Behr,et al. Etiology of Sudden Death in Sports: Insights From a United Kingdom Regional Registry. , 2016, Journal of the American College of Cardiology.
[12] B. Maron,et al. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Preamble, Principles, and General Considerations: A Scientific Statement From the American Heart Association and American College of Cardiology. , 2015, Circulation.
[13] F. Sacher,et al. Characterization of the Left-Sided Substrate in Arrhythmogenic Right Ventricular Cardiomyopathy , 2015, Circulation. Arrhythmia and electrophysiology.
[14] M. Link,et al. Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia , 2015, Circulation.
[15] D. Corrado,et al. Arrhythmogenic right ventricular cardiomyopathy and sports activity. , 2015, European heart journal.
[16] M. Link,et al. Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy. , 2015, European heart journal.
[17] Stefan L. Zimmerman,et al. Spectrum of Biventricular Involvement on CMR Among Carriers of ARVD/C-Associated Mutations. , 2015, JACC Cardiovascular Imaging.
[18] G. Thiene. The research venture in arrhythmogenic right ventricular cardiomyopathy: a paradigm of translational medicine. , 2015, European heart journal.
[19] H. Rehm,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.
[20] L. Monserrat,et al. Desmoplakin truncations and arrhythmogenic left ventricular cardiomyopathy: characterizing a phenotype. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[21] A. Gangi,et al. Left Ventricular Involvement in Arrhythmogenic Right Ventricular Cardiomyopathy – A Cardiac Magnetic Resonance Imaging Study , 2014, Clinical Medicine Insights. Cardiology.
[22] Stefan L. Zimmerman,et al. Mutation‐Positive Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: The Triangle of Dysplasia Displaced , 2013, Journal of cardiovascular electrophysiology.
[23] C. Tracy,et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. , 2013, Heart rhythm.
[24] Sungsam Gong,et al. Next Generation Diagnostics in Inherited Arrhythmia Syndromes , 2012, Journal of Cardiovascular Translational Research.
[25] R. Brugada,et al. Arrhythmogenic right ventricular cardiomyopathy: severe structural alterations are associated with inflammation , 2012, Journal of Clinical Pathology.
[26] Pablo Cingolani,et al. © 2012 Landes Bioscience. Do not distribute. , 2022 .
[27] J. Saffitz. Arrhythmogenic cardiomyopathy: advances in diagnosis and disease pathogenesis. , 2011, Circulation.
[28] Michael J Ackerman,et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[29] R. Hauer,et al. Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise. , 2011, Journal of the American College of Cardiology.
[30] H. Hakonarson,et al. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.
[31] Wojciech Zareba,et al. Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria , 2010, Circulation.
[32] Dudley J Pennell,et al. Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. , 2008, Journal of the American College of Cardiology.
[33] Sean Connors,et al. Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. , 2008, American journal of human genetics.
[34] Petros Syrris,et al. Clinical and Genetic Characterization of Families With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Provides Novel Insights Into Patterns of Disease Expression , 2007, Circulation.
[35] S. Russell,et al. Arrhythmogenic Right Ventricular Dysplasia: A United States Experience , 2005, Circulation.
[36] D. Malicier,et al. Circumstances of Death and Gross and Microscopic Observations in a Series of 200 Cases of Sudden Death Associated With Arrhythmogenic Right Ventricular Cardiomyopathy and/or Dysplasia , 2003, Circulation.
[37] D. Corrado,et al. Sudden cardiac death in young people with apparently normal heart. , 2001, Cardiovascular research.
[38] M. Davies,et al. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. , 1997, Journal of the American College of Cardiology.
[39] A. Angelini,et al. Arrhythmogenic right ventricular cardiomyopathy. Dysplasia, dystrophy, or myocarditis? , 1996, Circulation.
[40] R Frank,et al. Right Ventricular Dysplasia: A Report of 24 Adult Cases , 1982, Circulation.